These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The histological localisation of fibrinolysin activator. TODD AS J Pathol Bacteriol; 1959 Jul; 78():281-3. PubMed ID: 13838613 [No Abstract] [Full Text] [Related]
44. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis. Thorsen S; Astrup T Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113 [No Abstract] [Full Text] [Related]
45. Enhancement of vitreous clot lysis by urokinase: mode of action. Forrester JV; Edgar W; Millar W; Prentice CR; Williamson J Exp Eye Res; 1982 Jun; 34(6):895-907. PubMed ID: 6211365 [No Abstract] [Full Text] [Related]
46. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH; Diamond SL J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094 [TBL] [Abstract][Full Text] [Related]
47. Fibrinolytic activity of the vitreous body. Forrester JV; Prentice CR; Williamson J; Forbes CD Invest Ophthalmol; 1974 Nov; 13(11):875-9. PubMed ID: 4279343 [No Abstract] [Full Text] [Related]
48. Stimulation of fibrinolysis in the vitreous body. Pandolfi M Bibl Anat; 1979; (18):292-7. PubMed ID: 159041 [No Abstract] [Full Text] [Related]
49. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase]. Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011 [TBL] [Abstract][Full Text] [Related]
50. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]